scispace - formally typeset
M

Marcin F. Osuchowski

Researcher at Boston University

Publications -  77
Citations -  3993

Marcin F. Osuchowski is an academic researcher from Boston University. The author has contributed to research in topics: Sepsis & Medicine. The author has an hindex of 25, co-authored 69 publications receiving 3195 citations. Previous affiliations of Marcin F. Osuchowski include University of Michigan & University of Georgia.

Papers
More filters
Journal ArticleDOI

The Pathogenesis of Sepsis

TL;DR: Biomarkers may be used to help diagnose patients with sepsis, and they may also help to identify patients who would benefit from immunomodulatory therapies.
Journal ArticleDOI

Circulating Cytokine/Inhibitor Profiles Reshape the Understanding of the SIRS/CARS Continuum in Sepsis and Predict Mortality

TL;DR: It is demonstrated that the initial inflammatory response directly correlates to early but not late sepsis mortality, and this multifaceted response questions the use of a simple proinflammatory cytokine measurement for classifying the inflammatory status during septis.
Journal ArticleDOI

Sepsis: Multiple Abnormalities, Heterogeneous Responses, and Evolving Understanding

TL;DR: Given the complexity of sepsis, biomarkers and mathematical models offer potential guidance once they have been carefully validated to provide a framework for understanding the complex and current challenges of managing the septic patient.
Journal ArticleDOI

The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity.

TL;DR: The authors reviewed the intricacies of COVID-19 pathophysiology, its various phenotypes, and the anti-SARS-CoV-2 host response at the humoral and cellular levels.
Journal ArticleDOI

Current gaps in sepsis immunology: new opportunities for translational research.

TL;DR: The role of key immune cells, the cause of lymphopenia, organ-specific immunology, the dynamics of sepsis-associated immunological alterations, the role of the microbiome, the standardisation of immunological tests, the development of better animal models, and the opportunities offered by immunotherapy are discussed.